Showing results (121-130 of 287) with videos related to
Sort By:
Pageof 29
The European Respiratory Journal|June 13, 2001
Sparfloxacin in the treatment of drug resistant tuberculosis or intolerance of first line therapyA Lubasch, R Erbes, H Mauch, et al.Drugs of Today (Barcelona, Spain : 1998)|July 25, 2003
Clinical results in the treatment of respiratory infections with moxifloxacinH Lode, A Lubasch, M Raffenberg, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 13, 2001
Meropenem: clinical response in relation to in vitro susceptibilityG L Drusano, H Lode, J R EdwardsDeutsche Medizinische Wochenschrift (1946)|April 22, 1977
[Bacterial endocarditis. Clinical picture, treatment and course in 37 patients (author's transl)]H Lode, B Behn, H Langmaack, et al.Advances in Clinical Pharmacology|January 1, 1978
[Pharmacologic studies or aminoglycoside antibiotics (amikacin, gentamicin, sisomicin, tobramycin)]H Lode, K Grunert, B Kemmerich, et al.Pneumologie (Stuttgart, Germany)|July 20, 1999
[Inpatient treatment costs of exacerbated chronic obstructive lung disease]K Riecke, J Eller, C Gericke, et al.The Journal of Infectious Diseases|November 1, 1976
Pharmacokinetic and clinical studies with amikacin, a new aminoglycoside antibioticH Lode, K Grunert, P Koeppe, et al.Deutsche Medizinische Wochenschrift (1946)|September 3, 1976
[Pharmacokinetics and clinical experience with amikacin. A new aminoglycoside antibiotic]H Lode, K Grunert, P Koeppe, et al.The American Journal of Medicine|November 30, 1989
Ciprofloxacin intravenous dose varianceH Lode, G Hoffken, K Borner, et al.Arzneimittel-Forschung|January 1, 1980
[Comparative pharmacokinetics of oral cephalosporins: cephalexin, cefaclor and cefadroxil (author's transl)]H Lode, R Stahlmann, G Dzwillo, et al.Pageof 29